PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces the first close of its ...

A new study identifies Florida spot keratopathy (FSK) as a stable, benign eye condition in pets and suggests a possible link ...

Tashi was referred to a specialist in Southern California who at the time was the only ophthalmologist in California, to ...

Alumis Inc. will merge with a Southern California drug developer in a deal that extends the combined companies' cash into ...

The global veterinary eye care market size is estimated to grow by USD 1.05 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 5.62% during the forecast ...